Institutional Ownership Gain Therapeutics, Inc. (GANX)
This table provides information about the institutional ownership of Gain Therapeutics, Inc. (GANX). We have compiled data on the 42 institutions that hold shares in the stock, with a total of 5.02 Million shares, which have been reported (via 13F filing form) to have a value of $14.2 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jones Financial Companies Lllp
|
Nov 04, 2025 Q3 2025 |
676,822
shares
|
$1.92 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.01%
|
|
|
David Einhorn
Greenlight Capital Inc | New York, Ny
|
Feb 14, 2024 Q4 2023 |
588,410
shares
|
$1.67 Million
0.1% of portfolio
|
Q4 2023
Added 7.66%
|
|
|
Dme Capital Management, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
566,130
shares
|
$1.6 Million
0.04% of portfolio
|
Q1 2024
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
534,352
shares
|
$1.51 Million
0.0% of portfolio
|
Q2 2025
Added 109.56%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
373,558
shares
|
$1.06 Million
0.0% of portfolio
|
Q3 2025
Added 130.85%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
344,146
shares
|
$973,933
0.0% of portfolio
|
Q3 2025
Added 18.48%
|
|
|
Cambridge Investment Research Advisors, Inc.
|
Nov 12, 2025 Q3 2025 |
318,645
shares
|
$901,765
0.0% of portfolio
|
Q3 2025
Added 77.52%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
175,107
shares
|
$495,552
0.0% of portfolio
|
Q3 2025
Reduced 36.65%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
155,675
shares
|
$440,560
0.0% of portfolio
|
Q3 2025
Added 103.46%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
140,677
shares
|
$398,115
0.0% of portfolio
|
Q3 2025
Added 331.06%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
126,100
shares
|
$356,863
0.0% of portfolio
|
Q3 2025
Added 34.15%
|
|
|
Telemetry Investments, L.L.C.
New York, NY |
Feb 14, 2023 Q4 2022 |
123,000
shares
|
$348,090
0.61% of portfolio
|
Q4 2022
Reduced 18.0%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
91,137
shares
|
$257,917
0.0% of portfolio
|
Q3 2025
Added 28.11%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
88,399
shares
|
$250,169
0.0% of portfolio
|
Q3 2025
Reduced 11.75%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
84,620
shares
|
$239,474
0.0% of portfolio
|
Q2 2024
Added 12.23%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
80,435
shares
|
$227,631
0.0% of portfolio
|
Q3 2025
Added 1.11%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
72,450
shares
|
$205,033
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
54,202
shares
|
$153,391
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Virtu Financial LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
54,008
shares
|
$152,842
0.01% of portfolio
|
Q3 2025
Added 126.91%
|
|
|
Kovitz Investment Group Partners, LLC
|
Nov 10, 2025 Q3 2025 |
47,578
shares
|
$134,645
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
38,537
shares
|
$109,059
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Prelude Capital Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
35,820
shares
|
$101,370
0.01% of portfolio
|
Q1 2024
Reduced 38.35%
|
|
|
Benedict Financial Advisors Inc
|
Nov 03, 2025 Q3 2025 |
35,000
shares
|
$99,050
0.01% of portfolio
|
Q3 2025
Added 55.56%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2025 Q3 2025 |
30,004
shares
|
$84,911
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Two Sigma Securities, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
27,323
shares
|
$77,324
0.01% of portfolio
|
Q3 2025
New holding
|
|